NCT00412854View on ClinicalTrials.gov

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

PHASE3CompletedINTERVENTIONAL

Enrollment

660

Participants

Timeline

Start Date

January 3, 2007

Primary Completion Date

June 1, 2007

Study Completion Date

June 25, 2007

Conditions

TetanusDiphtheriaAcellular Pertussis

Interventions

BIOLOGICAL

Infanrix™/Hib

BIOLOGICAL

Infanrix

BIOLOGICAL

Hiberix

Trial Locations (2)

Unknown

GSK Investigational Site, Mengshan

GSK Investigational Site, Wuzhou

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY